Calls Purchased on GTx, Inc.
Shares of GTx, Inc. (NASDAQ: GTXI) are higher on the session by 10.67%, currently trading at $5.81. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average.
Options traders are buying calls on the name today. A short while ago the July 2011 $7.00 call was purchased 500 times, on the offer, on open interest of 44 contracts.
Overall call volume is now running at 5.89x the daily average with 92% of all calls traded being purchases on the offer.
GTx, Inc. is a biopharmaceutical company dedicated to the discovery, development and commercialization of small molecules that targets hormone pathways to treat cancer, osteoporosis and bone loss, muscle loss and other serious medical conditions.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.